Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
First Edition BOGP (0)
États-Unis (2)
Other
Neurology/Parkinson's Disease (1)
Patient Advocacy Organization (4)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Representativeness of stakeholders
Clinical study phase II